Polen Capital Management »

Biosante Pharmaceuticals shares owned by Polen Capital Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Polen Capital Management from 13F filings

Historical chart of Polen Capital Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Polen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Polen Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $493k 6.4k 76.90

More positions owned by Polen Capital Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Servicenow (NOW)
Shopify Cl A Sub Vtg Shs (SHOP)
Visa Com Cl A (V)
Oracle Corporation (ORCL)
NVIDIA Corporation (NVDA)
CoStar (CSGP)
Msci (MSCI)
Zoetis Cl A (ZTS)
Starbucks Corporation (SBUX)

View all positions for Polen Capital Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
Deep Track Capital
Millennium Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Nuveen
Vanguard Portfolio Management
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals